Detection Kit for Monkeypox Virus ( Real-time PCR ) is designed for the qualitative detection of Monkeypox Virus (MPV) DNA extracted from skin, fluid, or crusts collected directly from skin lesions. It's based on real-time PCR technology, the primers and probes target specific sequences of MPV, and do not react with nucleic acids of other pathogens.
COVID-19 Ag & Flu A/B Combo Self Test is a colloidal gold immunochromatography intended for the in vitro rapid, simultaneous qualitative detection and differentiation of N protein from SARS-CoV-2, influenza A and influenza B directly from nasal swab specimens obtained from individuals, who are suspected of COVID-19, influenza A or influenza B infection. Results are for the simultaneous identification of N protein of SARS-CoV-2, influenza A and influenza B.
Affinity A1c Analyzer is a quantitative detection system based on boronate affinity chromatography, which is used with glycohemoglobin test kit to detect the level of hemoglobin A1c (HbA1c) in human whole blood (venous blood/finger prick).
Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
Biotime SARS-CoV-2 Antigen rapid test is a fluorescence immunoassay(FIA) for the quantitative detection of SARS-CoV-2 in human nasal swab. It is useful as an aid in monitoring and management of COVID-19 infection.
The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.
The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.
The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.
IPv6 network supported 
